Publication

Bile acids drive colonic secretion of glucagon-like-peptide 1 and peptide-YY in rodents

Related publications (32)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Bile acids drive colonic secretion of glucagon-like-peptide 1 and peptide-YY in rodents

Graph Chatbot

Chat with Graph Search

The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation

Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output

Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function

Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism

Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes

Molecular field analysis and 3D-quantitative structure-activity relationship study (MFA 3D-QSAR) unveil novel features of bile acid recognition at TGR5

Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies

Targeting bile-acid signalling for metabolic diseases

In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue

Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation